Boulder, CO, United States of America

Sumedha D Jayasena

This inventor holds 27 USPTO granted patents and 1 published patent application and 6 EPO patents, primarily in Nucleic Acid Diagnostics. Top assignees: Nexstar Pharmaceuticals, Inc., Somalogic, Incorporated, Gilead Sciences, Inc.. Active years: 1995-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumedha D Jayasena. Retrieved from https://idiyas.com/inventor/sumedha-d-jayasena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.9

ph-index = 19

Forward Citations = 1,489(Granted Patents)


Company Filing History:


Years Active: 1995-2003

Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid
Diagnostic Biochip
Ligand Interaction
High Affinity Ligands
Blended SELEX
Cytokines
DNA Polymerases
Homogeneous Detection
Flow Cytometry
Enzyme Linked Assays
Neutrophil Elastase
27 patents (USPTO):Explore Patents

Sure, here is the article about inventor Sumedha D Jayasena:

Title: Unraveling the Innovations of Inventor Sumedha D Jayasena

Introduction:

Sumedha D Jayasena, a brilliant inventor based in Boulder, CO (US), has made significant contributions to the field of diagnostics and molecular assays. With an impressive total of 27 patents to his name, Jayasena is a pioneer in developing cutting-edge technologies for medical applications.

Latest Patents:

1. Nucleic Acid Ligand Diagnostic Biochip: Jayasena's diagnostic biochip revolutionizes the field by offering a spatially defined platform for specific nucleic acid ligands to bind to target molecules in bodily fluids. This innovation opens new possibilities for medical diagnosis and quantitative detection of various conditions.

2. Homogeneous Detection of a Target through Nucleic Acid Ligand-Ligand Beacon Interaction: Jayasena's ligand beacon assay presents a fast and efficient method for detecting target molecules using molecular beacons and nucleic acid ligands. This assay boasts high specificity and affinity, making it ideal for clinical applications and high-throughput screening.

Career Highlights:

Sumedha D Jayasena has showcased his expertise in various renowned companies, including Nexstar Pharmaceuticals, Inc. and Somalogic, Incorporated. Throughout his career, Jayasena has been dedicated to pushing the boundaries of innovation in the field of molecular diagnostics and biochemistry.

Collaborations:

Jayasena has had the privilege of working alongside industry luminaries such as Larry M Gold and Dan W Drolet. These collaborations have led to the development of groundbreaking technologies and have propelled the field of molecular assays forward.

Conclusion:

In conclusion, Sumedha D Jayasena stands out as a visionary inventor whose contributions have greatly influenced the landscape of molecular diagnostics. His innovative approaches and dedication to advancing medical technologies continue to inspire future generations of inventors in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…